Rybelsus® is a brand name for the medication Semaglutide and is classified as a glucagon-like peptide 1 (GLP-1). It is the first oral medication of its kind to be approved by the FDA and is used to treat Class 2 diabetes – a condition where the patient’s body produces insufficient insulin or doesn’t use produced insulin efficiently.

Showing the single result

  • Rybelsus (Semaglutide) Tablets

    $299.79

    Allergic Reactions

    As with most drugs, some people can have an allergic reaction after taking Rybelsus. However, it’s not known how often allergic reactions occur with Rybelsus.

    Symptoms of a mild allergic reaction can include: skin rash, itchiness and flushing (warmth and redness in your skin).

    A more severe allergic reaction is rare but possible. Symptoms of a severe allergic reaction can include: swelling under your skin (typically in your eyelids, lips, hands, or feet), swelling of your tongue, mouth, or throat and trouble breathing or speaking.

    Call your doctor right away if you have a severe allergic reaction to Rybelsus. Call 911 if your symptoms feel life threatening or if you think you’re having a medical emergency.